Sign Up to like & get
recommendations!
0
Published in 2021 at "Nucleic Acids Research"
DOI: 10.1093/nar/gkab154
Abstract: Abstract Hydroxamate-based lysine deacetylase inhibitors (KDACis) are approved for clinical use against certain cancers. However, intrinsic and acquired resistance presents a major problem. Treatment of cells with hydroxamates such as trichostatin A (TSA) leads to…
read more here.
Keywords:
acetylation;
sensitivity;
h3k4me3;
directed acetylation ... See more keywords